{"date":"2025-01-13","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4728-2025-01-13-2146-ep52nc","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-01-13","time":"21:46:52","subject":"公告本公司獨立董事對薪酬委員會及董事會決議事項表示反對意見","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-01-13 21:46，「公告本公司獨立董事對薪酬委員會及董事會決議事項表示反對意見」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-01-13-1428-lj75ro","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-01-13","time":"14:28:09","subject":"公告本公司第三次買回庫藏股期間屆滿執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-01-13 14:28，「公告本公司第三次買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}